Eric Topol (05:36): Well, also just to set the foundation here, which you alluded to, there had been so many attempts to come up with a drug that would work, not just of course in diabetes where there are many classes of drugs, but moreover, to treat the condition of obesity
doi: 10.1111/exd.12621 46 BeschRPoeckHHohenauerTSenftDHackerGBerkingCet al
We also rely on micronutrient testing to get a forward-looking analysis of vitamin and mineral deficiencies something thats especially important for people using GLP-1s, where eating less can quietly mean absorbing less. One of the biggest misconceptions that Berjis hears when it comes to using GLP-1s
It binds with high affinity across multiple melanocortin receptor subtypes: MC1R (Ki approximately 0.67 nM), MC4R (approximately 6.6 nM), MC3R (approximately 34 nM), and MC5R (approximately 46 nM)